Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 14, Issue 5, 2008, Pages 645-651

  Simondi, Daniele ^a   Mengozzi, Giulio ^a   Betteto, Silvia ^a   Bonardi, Renato ^a   Ghignone, Roberta Patrizia ^a   Fagoonee, Sharmila ^b   Pellicano, Rinaldo ^a   Sguazzini, Carlo ^a   Pagni, Roberto ^a   Rizzetto, Mario ^a   Astegiano, Marco ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti Saccharomyces cerevisiae antibodies; Crohn's disease; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; CELL ANTIBODY; CHITOBIOSIDE CARBOHYDRATE ANTIBODY; FUNGUS ANTIBODY; GLYCAN ANTIBODY; LAMINARIBIOSIDE ANTIBODY; MANNOBIOSIDE CARBOHYDRATE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL PRACTICE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENTERITIS; ENZYME IMMUNOASSAY; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT REFERRAL; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SMALL INTESTINE MUCOSA; TERTIARY HEALTH CARE; ULCERATIVE COLITIS;

EID: 44349145098     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20368     Document Type: Article

References (25)

1. Broberger O, Perlmann P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959;110:657-679.
2. Seibold F, Mork H, Tanza S, et al. Pancreatic autoantibodies in Crohn's disease: a family study. Gut. 1997;40:481-484.
3. Berberian LS, Valles-Ayoub Y, et al. Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. J Immunol. 1994;153:3756-3763.
4. Aldebert D, Masy E, Reumaux D, et al. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease. Dig Dis Sci. 1997;42:2350-2355.
5. Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest. 1985;76:311-318.
6. Brandtzaeg P, Baklien K, Fausa O, et al. Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis. Gastroenterology. 1974;66:1123-1136.
7. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730-734.
8. Koutroubakis IE, Petinaki E, Mouzas IA, et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:449-454.
9. Sandborn WJ, Loftus EV Jr, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2001;7:192-201.
10. Dotan I, Fishman S, Dgani Y, et al. Antibodies against Laminaribioside and Chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006;131:366-378.
11. Dotan N, Altstock RT, Schwarz M, et al. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus. 2006;15:442-450.
12. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 200756:1394-1403.
13. Pellicano R, Bonardi R, Smedile A, et al M. Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report. Minerva Med. 2007;98:19-23.
14. Stange EF, Travis SPL, Vermeire S, et al; European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55:1-15.
15. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the working party of the world congresses of gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
16. Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2001;96:635-643.
17. Henckaerts L, Pierik M, Claes K, et al. Mutations in innate immune receptors modulate the serologic response to microbial antigens in patients with inflammatory bowel disease. Gastroenterology. 2006;130(Suppl 2):A585.
18. Vermeire S, Peeters M, Vlietinck R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis. 2001;7:8-15.
19. Secondulfo M, De Magistris L, Fiandra R, et al. Intestinal permeability in Crohn's disease patients and their first degree relatives. Digest Liver Dis 2001;33:680-685.
20. Harrer M, Reinisch W, Dejaco C, et al. Do high serum levels of anti-Saccharomyces cerevisae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol. 2003;15:1281-1285.
21. Damoiseaux JG, Bouten B, Linders AM, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol. 2002;22:281-288.
22. Granito A, Zauli D, Muratori P, et al. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in celiac disease before and after gluten-free diet. Aliment Pharmacol Ther. 2005;21:881-887.
23. Israeli E, Grotto I, Gilburd B, et al Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005;54:1232-1236.
24. Arnott ID, Landers CJ, Nimmo EJ, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004;99:2376-2384.
25. Halfvarson J, Standaert-Vitse A, Jarnerot G, et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut. 2005;54:1237-1243.